CD2H COVID-19

Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic

Purpose

The primary goal of this project is to identify the best messaging and implementation strategies to maximize SARS-CoV-2 testing for children with intellectual and developmental disabilities (IDD) and their teachers to help ensure a safe school environment. Additionally, we will understand nationally the perceptions of COVID-19 and identify facilitators and barriers to help with the adoption of testing in other parts of the US and the necessary strategies to address other mitigation strategies including vaccination.

Conditions

Covid19
Intellectual Disability
Developmental Disability
Child Development Disorder

Eligibility

Eligible Ages: Between 5 Years and 90 Years
Eligible Sex: All
Accepts Healthy Volunteers: Yes

Inclusion Criteria

Students enrolled in the St. Louis Special School District or the Kennedy Krieger Institutes/Sheppard Pratt Schools in Maryland. - Teachers/Staff working at the St. Louis Special Schools or the Kennedy Krieger Institutes/Sheppard Pratt Schools in Maryland dedicated to teaching children with IDD. or - Parents/ of students, teachers and/or staff employed by the St. Louis Special School District or Kennedy Krieger Institute/Sheppard Pratt schools in Maryland or - Families, teachers, and staff of the 67 University Centers for Excellence in Developmental Disabilities (UCEDD) which is sponsored by the Association of University Centers for Disability (AUCD).

Exclusion Criteria

Members of the research team will not be eligible to participate in the focus groups.

Study Design

Phase: N/A
Study Type: Interventional
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description: A cluster randomized adaptive trial will be conducted. The first phase will randomize the 6 Special School District schools to either a general message or focus/targeted message. Data analysis will occur and then the schools will be randomized to the best message strategy from phase 1 alone or best message plus and augmented message or implementation strategy. The same process will take place independently at the Kennedy Krieger Institutes/Sheppard Pratt Schools.
Primary Purpose: Health Services Research
Masking: None (Open Label)

Arm Groups

Arm	Description	Assigned Intervention
Active Comparator SSD: Standard Messaging - Standard Messaging	In phase 1, all schools received standard messaging. In phase 2, three schools were randomized to standard messaging.	Behavioral: Standard Messaging A messaging strategy will be developed from focus groups that generally describes COVID-19 and the importance of testing. Diagnostic Test: COVID-19 Testing Weekly surveillance COVID-19 testing.
Active Comparator SSD: Standard Messaging - Enhanced Messaging	In phase 1, all schools received standard messaging. In phase 2, three schools were randomized to a messaging strategy that was developed from focus groups that were targeted to address specific concerns of the different communities.	Behavioral: Standard Messaging A messaging strategy will be developed from focus groups that generally describes COVID-19 and the importance of testing. Behavioral: Enhanced Messaging A messaging strategy that is developed from focus groups that is targeted to address specific concerns of the different communities. Messages may target groups being tested (staff versus students) or sociodemographic or race/ethnicity differences between schools depending on the focus groups input. Diagnostic Test: COVID-19 Testing Weekly surveillance COVID-19 testing.
Active Comparator KKI: Standard Messaging - Standard Messaging	In phase 1, all schools received standard messaging. In phase 2, two schools were randomized to standard messaging.	Behavioral: Standard Messaging A messaging strategy will be developed from focus groups that generally describes COVID-19 and the importance of testing. Diagnostic Test: COVID-19 Testing Weekly surveillance COVID-19 testing.
Active Comparator KKI: Standard Messaging - Enhanced Messaging	In phase 1, all schools received standard messaging. In phase 2, two schools were randomized to a messaging strategy that was developed from focus groups that were targeted to address specific concerns of the different communities.	Behavioral: Standard Messaging A messaging strategy will be developed from focus groups that generally describes COVID-19 and the importance of testing. Behavioral: Enhanced Messaging A messaging strategy that is developed from focus groups that is targeted to address specific concerns of the different communities. Messages may target groups being tested (staff versus students) or sociodemographic or race/ethnicity differences between schools depending on the focus groups input. Diagnostic Test: COVID-19 Testing Weekly surveillance COVID-19 testing.
Experimental Focus Groups	Focus group were completed in Phase 1 to develop enhanced messaging. Focus group participants were not required to be enrolled in testing.	Behavioral: Focus Groups Focus groups to develop enhanced messaging.
Experimental Fuzzy Cognitive Mapping	FCMs were completed to assess the facilitators and barriers to testing. FCM participants were not required to be enrolled testing.	Behavioral: Fuzzy Cognitive Mapping FCMs to assess facilitators and barriers to COVID-19 testing.

Recruiting Locations

More Details

NCT ID: NCT04565509
Status: Completed
Sponsor: Washington University School of Medicine

Detailed Description

This research study will occur at six schools dedicated to children with IDD that are a part of the Special School Districts in St. Louis, MO. Additionally, surveys, focus groups, and fuzzy cognitive mapping sessions will be conducted at these six schools and at schools within the Kennedy Krieger School Programs in Baltimore, MD. Finally, a national survey will be administered to families, teachers, and staff of the 67 University Centers for Excellence in Developmental Disabilities (UCEDD) which is sponsored by the Association of University Centers for Disability (AUCD). The first aim will involve focus groups of parents/guardians, teachers, and school staff to identify the barriers and facilitators to frequent SARS-CoV-2 testing, impressions of COVID-19, and best messages and implementation strategies to promote increase testing and vaccination. A formal process for developing two types of messages (general versus focused) will be performed using focus group data and involving key stakeholders to test the messages. A cluster randomized adaptive clinical trial will then occur at the six special school district schools. In phase 1, the schools will be randomized initially to either the general or focused message to promote the adoption of weekly SARS-CoV-2 testing by the students and teachers. After 5 months, data analysis will be conducted to determine which strategy led to the highest percentage of testing. Phase 2 will begin at 7 months after the schools are randomized to either the best message determined from phase 1 or best message plus an augmented implementation strategy. Beginning in April 2021 the first aim was expanded to include weekly testing and message development at the Kennedy Krieger Institutes and Sheppard Pratt Schools in Baltimore, MD. In phase 1, these schools will be randomized initially to either the general or focused message to promote the adoption of weekly SARS-CoV-2 testing by the students and teachers. After 5 months, data analysis will be conducted to determine which strategy led to the highest percentage of testing. Phase 2 will begin at 7 months after these schools are randomized to either the best message determined from phase 1 or best message plus an augmented implementation strategy. The second aim will assess the national perspectives among parents of children with IDD and school staff regarding the impact of COVID-19 and importance of SARS-CoV-2 testing. Fuzzy cognitive mapping (FCM) and the administration of local and national surveys will be used to accomplish this aim. FCM will involve in-person sessions with parents from the schools in aim 1 and Kennedy Krieger Institute/Sheppard Pratt schools in Baltimore, MD for children with IDD. These sessions will help identify the facilitators and barriers SARS-CoV-2 testing and other mitigation strategies including COVID-19 vaccine. Since no accepted measures have been developed for understanding parent and school staff concerns for children with IDD around COVID-19, local (St. Louis and Baltimore) and national surveys will be conducted. Custom surveys will be deployed across two stakeholder groups: parent/guardians and school staff. We will administer the survey at baseline and during the trial across school settings (St. Louis and Baltimore). A national survey will also be administered across the UCEDDs. Psychometric analysis will be performed to help identify the questions for a national survey at the end of the study period. In addition to the custom surveys, NIH recommended parent-report surveys from the PhenX Toolkit will be used. The surveys to be used include the Psychological Stress Associated with the COVID-19 Crisis Scale and COVID-19 impact questionnaires.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.